|
EFCAB7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.70735999999172E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.580500E-03 |
| Normal-vs-Stage2 |
2.600200E-01 |
| Normal-vs-Stage3 |
1.04560000002696E-06 |
| Normal-vs-Stage4 |
2.64179999986958E-07 |
| Stage1-vs-Stage2 |
7.973600E-01 |
| Stage1-vs-Stage3 |
1.025680E-02 |
| Stage1-vs-Stage4 |
2.800000E-03 |
| Stage2-vs-Stage3 |
1.097020E-01 |
| Stage2-vs-Stage4 |
6.858400E-02 |
| Stage3-vs-Stage4 |
7.051000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.89999999999202E-05 |
| Normal-vs-AfricanAmerican |
3.82960000000487E-05 |
| Normal-vs-Asian |
7.825800E-01 |
| Caucasian-vs-AfricanAmerican |
7.907800E-02 |
| Caucasian-vs-Asian |
4.984600E-01 |
| AfricanAmerican-vs-Asian |
1.591770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.98340000043562E-07 |
| Normal-vs-Female |
2.105800E-02 |
| Male-vs-Female |
2.070400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.563800E-04 |
| Normal-vs-Age(41-60Yrs) |
1.584840E-03 |
| Normal-vs-Age(61-80Yrs) |
2.16219999999989E-05 |
| Normal-vs-Age(81-100Yrs) |
3.875800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.726960E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.431200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.000800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.695800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.903000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.941400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.428400E-01 |
| Normal-vs-Grade 2 |
1.631040E-01 |
| Normal-vs-Grade 3 |
6.70590000195759E-08 |
| Normal-vs-Grade 4 |
4.55502302543209E-12 |
| Grade 1-vs-Grade 2 |
1.286440E-01 |
| Grade 1-vs-Grade 3 |
3.699300E-03 |
| Grade 1-vs-Grade 4 |
3.27619999995754E-06 |
| Grade 2-vs-Grade 3 |
2.795300E-04 |
| Grade 2-vs-Grade 4 |
7.49939998989646E-09 |
| Grade 3-vs-Grade 4 |
4.056300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.574400E-01 |
| Normal-vs-ccB subtype |
2.44190001552624E-09 |
| ccA subtype-vs-ccB subtype |
1.08259999853644E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.396660E-03 |
| Normal-vs-N1 |
5.542000E-03 |
| N0-vs-N1 |
5.004400E-01 |
|
|
